OneMedResearch Global Report:
COVID-19 TESTS
A vast market created overnight.
Access to tests has become a critical health need in the United States and Worldwide as the sudden unexpected tsunami has strained the healthcare system. Testing is regarded as the key to addressing the pandemic.
A Global Research Effort.
A team of researchers in both the United States and Europe have produced a report on all significant tests in development.
This written report and an online database will provide a starting point for collaboration as it will provide a mechanism to understand the technologies and projects that have the greatest prospect of addressing this challenge. Our objective is to identify those with greatest potential,
Contents
Core Testing Technologies
-
RNA tests. Lab Tests PCR.
-
Serology tests. Blood tests.
-
Emerging areas. Digital imaging, temperature sensors.
The Supply Chain
-
Existing organizations. Industry size and structure. Profile of the primary suppliers.
-
Complementary Products and equipment. Capital equipment, RT-PCR instruments, reagents, swabs, and disposables
Commercialization Issues
-
Channel Distribution. Hospitals. Clinics, Pharmacy Store Pathology Centers.
Company Profiles
-
A profile on 160 companies with meaningful products related to improving the quality and reach of diagnostic testing related to coronavirus.
Observations and Recommendations
-
Channel Distribution. Hospitals. Clinics, Pharmacy Store Pathology Centers
Company Data Collected
For each company we will provide 16 key data points..
-
Overview of firm.
-
Technology summary.
-
Clinical need
-
Testing type.
-
Test sample type.
-
Time to result.
-
Technology overview
-
Required to perform.
-
Setting of care.
-
Data of effectiveness.
-
Current status
-
Business model.
-
Funding and ownership.
-
Intellectual property.
-
History and origins.
-
Organization.
To receive our White Paper on What Investors Should Know About COVID-19, click here and take our short survey.
Included in COVID Testing Reports
-
70 US companies at some stage of the FDA approval. (United States only).
-
90 Ex US companies. At some stage of the CE mark approval. (Europe)
Included companies:
-
3D Medicines
-
Abbott Diagnostics Inc.
-
Abbott Molecular Inc.
-
Abwiz Bio
-
Aldatu Biosciences
-
altona Diagnostics GmbH
-
Atila BioSystems, Inc.
-
Ativa Medical
-
Autobio Diagnostics Co.
-
Avellino Lab USA, Inc.
-
Becton Dickinson
-
BGI Genomics Co. Ltd
-
Biocerna
-
BioFire Defense, LLC
-
BioMérieux SA
-
Bio-Rad Laboratories Inc.
-
Bright Line Research
-
Calbiotech, Inc.
-
Caspr Biotech
-
Cellex Inc.
-
Cepheid
-
Chembio Diagnostics
-
Co-Diagnostics, Inc.
-
Coyote Bioscience
-
DiaCarta, Inc
-
DiaSorin Inc.
-
DiaSorin Molecular, LLC
-
DNA Software, Inc.
-
EUROIMMUN AG
-
Fast Track Diagnostics
-
FemtoDx
-
Fluxergy LLC
-
Fosun Pharma USA Inc.
-
GenMark Diagnostics
-
GenoSensor, LLC
-
Gnomegen LLC
-
Hologic
-
InBios International, Inc
-
InDevR Inc.
-
Intrasense SA
-
Ipsum Diagnostics, LLC
-
IVDbio Inc.
-
Jetta Labs LLP
-
Jiangsu Superbio Biomedical Technology (Nanjing) Co., Ltd
-
Kephera Diagnostics
-
LabGenomics Co., Ltd
-
LGC Biosearch technology
-
Lifeassay Diagnostics Pty
-
Luminex Corp.
-
Luminostics, Inc.
-
Maccura Biotechnology
-
Mammoth Biosciences
-
Mesa Biotech Inc.
-
NeuMoDx Molecular, Inc.
-
Next Pharma Inc.
-
Novacyt/primerdesign
-
OPTI Medical Systems, Inc.
-
Orig3n, Inc.
-
Ortho Clinical Diagnostics
-
OSANG Healthcare
-
PerkinElmer, Inc.
-
Pinpoint Science Inc.
-
Predigen Inc.
-
Primerdesign Ltd.
-
QIAGEN GmbH
-
Quansys Biosciences
-
QuantuMDx
-
Quidel
-
Quotient Limited SA
-
RetroVirox Inc.
-
Rheonix, Inc.
-
Roche Molecular
-
Saladax Biomedical Inc.
-
Sansure BioTech Inc.
-
ScienCell Research
-
SD Biosensor, Inc.
-
SEASUN BIOMATERIALS
-
Seegene, Inc.
-
Sherlock Biosciences
-
The Corona Initiative, PBC
-
Thermo Fisher Scientific
-
Trax Management Services
-
Twist Bioscience
-
Ultimate Dx Laboratory
-
Vela Diagnostics Great Basin System
-
Zalgen Labs, LLC
-
Zymo Research Corp.
Research Reports Now Available! For more information or to request a sample please contact: info@virusproject.org